A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The major efficacy trials on diabetes prevention have used resource-intensive approaches to identify high-risk individuals and deliver lifestyle interventions. Such strategies are not feasible for wider implementation in low- and middle-income countries (LMICs). We aimed to evaluate the effectiveness of a peer-support lifestyle intervention in preventing type 2 diabetes among high-risk individuals identified on the basis of a simple diabetes risk score. METHODS AND FINDINGS: The Kerala Diabetes Prevention Program was a cluster-randomized controlled trial conducted in 60 polling areas (clusters) of Neyyattinkara taluk (subdistrict) in Trivandrum district, Kerala state, India. Participants (age 30-60 years) were those with an Indian Diabetes Risk Score (IDRS) ≥60 and were free of diabetes on an oral glucose tolerance test (OGTT). A total of 1,007 participants (47.2% female) were enrolled (507 in the control group and 500 in the intervention group). Participants from intervention clusters participated in a 12-month community-based peer-support program comprising 15 group sessions (12 of which were led by trained lay peer leaders) and a range of community activities to support lifestyle change. Participants from control clusters received an education booklet with lifestyle change advice. The primary outcome was the incidence of diabetes at 24 months, diagnosed by an annual OGTT. Secondary outcomes were behavioral, clinical, and biochemical characteristics and health-related quality of life (HRQoL). A total of 964 (95.7%) participants were followed up at 24 months. Baseline characteristics of clusters and participants were similar between the study groups. After a median follow-up of 24 months, diabetes developed in 17.1% (79/463) of control participants and 14.9% (68/456) of intervention participants (relative risk [RR] 0.88, 95% CI 0.66-1.16, p = 0.36). At 24 months, compared with the control group, intervention participants had a greater reduction in IDRS score (mean difference: -1.50 points, p = 0.022) and alcohol use (RR 0.77, p = 0.018) and a greater increase in fruit and vegetable intake (≥5 servings/day) (RR 1.83, p = 0.008) and physical functioning score of the HRQoL scale (mean difference: 3.9 score, p = 0.016). The cost of delivering the peer-support intervention was US$22.5 per participant. There were no adverse events related to the intervention. We did not adjust for multiple comparisons, which may have increased the overall type I error rate. CONCLUSIONS: A low-cost community-based peer-support lifestyle intervention resulted in a nonsignificant reduction in diabetes incidence in this high-risk population at 24 months. However, there were significant improvements in some cardiovascular risk factors and physical functioning score of the HRQoL scale. TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Registry ACTRN12611000262909.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 2×
“In the United States Diabetes Prevention Program (US DPP) [2], participants in the lifestyle intervention group received 16 individual counselling sessions from case managers within the first 24 weeks following randomization, and then, face-to-face contacts (individual or group) were made every two months for another…”
MethodResultTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In the Finnish Diabetes Prevention Study [5], participants received one-to-one individualized counselling sessions from nutritionists.”
BackgroundConsort 2010 statement: extension to cluster randomised trials
Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & for the CONSORT Group (2012) · BMJ · doi:10.1136/bmj.e5661 · Cited by 3,510 · cited 1×
“This study is reported in accordance with the Consolidated Standards of Reporting Trials guidelines for cluster RCTs (S1 Checklist) [19].”
MethodInternational Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Schwarzer, R. (2008) · Applied Psychology · doi:10.1111/j.1464-0597.2007.00325.x · Cited by 2,569
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
A Primer on Effectiveness and Efficacy Trials
Singal, A. G., Higgins, P. D. R., & Waljee, A. K. (2014) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2013.13 · Cited by 698
Risk models and scores for type 2 diabetes: systematic review
Noble, D., Mathur, R., Dent, T., Meads, C., & Greenhalgh, T. (2011) · BMJ · doi:10.1136/bmj.d7163 · Cited by 551
Dunkley, A. J., Bodicoat, D. H., Greaves, C. J., Russell, C., Yates, T., Davies, M. J., & Khunti, K. (2014) · Diabetes Care · doi:10.2337/dc13-2195 · Cited by 542 · cited 1×
“However, given that the efficacy of lifestyle interventions to prevent diabetes among high-risk individuals, particularly among those with IGT, has been quite well established, it is now important to determine their effectiveness in real-world settings, in which the target population is likely to be much broader if pr…”
BackgroundRamachandran, A., Snehalatha, C., Ram, J., Selvam, S., Simon, M., Nanditha, A., Shetty, A. S., Godsland, I. F., Chaturvedi, N., Majeed, A., et al. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70067-6 · Cited by 330
Cited by
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
The Challenges in the Development of Diabetes Prevention and Care Models in Low-Income Settings
Karachaliou, F., Simatos, G., & Simatou, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00518 · Cited by 120
Bell, K., Shaw, J. E., Maple-Brown, L., Ferris, W., Gray, S., Murfet, G., Flavel, R., Maynard, B., Ryrie, H., Pritchard, B., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108188 · Cited by 64
“[21] Thankappan KR, Sathish T, Tapp RJ, Shaw JE, Lotfaliany M, Wolfe R, et al.”
BackgroundSelf-citationMorrison, J., Akter, K., Jennings, H. M., Kuddus, A., Nahar, T., King, C., Shaha, S. K., Ahmed, N., Haghparast-Bidgoli, H., Costello, A., et al. (2019) · Global Health Research and Policy · doi:10.1186/s41256-019-0110-6 · Cited by 19
Wang, Y., Chai, X., Wang, Y., Yin, X., Huang, X., Gong, Q., Zhang, J., Shao, R., & Li, G. (2025) · Journal of Medical Internet Research · doi:10.2196/63975 · Cited by 14
“Among 30 studies that reported T2DM incidence as the outcome, 10 studies were classified as “low risk” [9,10,32,36,42,44,45,48,52,56], 7 studies as having “some concerns” [7,8,31,33,39,40,54], and the remaining 13 studies as “high risk” [11,34,35,37,38,41,43,46,47,49-51, 53], assessed by RoB 2.0…”
InfluentialTang, T. S., Sidhu, R., Halani, K., Elliott, T., Sohal, P., & Garg, A. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.11.003 · Cited by 7
Metadata
- Authors
- Thankappan, K. R., Sathish, T., Tapp, R. J., Shaw, J. E., Lotfaliany, M., Wolfe, R., Absetz, P., Mathews, E., Aziz, Z., Williams, E. D., Fisher, E. B., Zimmet, P. Z., Mahal, A., Balachandran, S., D'Esposito, F., Sajeev, P., Thomas, E., & Oldenburg, B.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-06-06
- Volume
- 15
- Issue
- 6
- Pages
- e1002575
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2805991586
- Cited by
- 194
- References
- 15
- FWCI
- 11.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.